Dr. Donovan – Ruxolitinib: A Potentially New Treatment for Alopecia Areata
Researchers from New York’s Columbia University have uncovered a potentially new treatment for alopecia areata: an oral cancer drug known as ruxolitinib.
Dr. Donovan’s Response – Tofacitinib (Xeljanz) for Treating Alopecia
We are pleased to share with you Dr. Jeff Donovan's response to the new information regarding Tofacitinib (Xeljanz) for treating Alopecia; to find out more please